The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Dialectic Therapeutics
Leadership - Dialectic Therapeutics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Bristol-Myers Squibb; Dialectic Therapeutics; Intuitive Surgical; Johnson & Johnson; Merck; Regeneron
Consulting or Advisory Role - Binhui Biopharmaceuticals, Ltd.; Synlogic
Research Funding - Agenus; Alkermes; Arvinas; AstraZeneca; BerGenBio; Daiichi Sankyo; Epizyme; Gan & Lee; Genmab; GlaxoSmithKline; Harpoon therapeutics; Hutchison MediPharma; Jounce Therapeutics; Laekna Therapeutics; Mirati Therapeutics; Mundipharma; Novartis; Odonate Therapeutics; Onconova Therapeutics; ORIC Pharmaceuticals; Pfizer; Rgenix; Shasqi Inc.; Surface Oncology; Synlogic; Takeda; Xenocor
A phase II trial combining tumor-targeting TP53 gene therapy with gemcitabine/nab-paclitaxel as a second-line treatment for metastatic pancreatic cancer.
 
Chris Poki Leung
Employment - Synergene Therapeutics
Stock and Other Ownership Interests - Synergene Therapeutics
Consulting or Advisory Role - Synergene Therapeutics (I)
 
Minal A. Barve
Employment - Texas Oncology
Stock and Other Ownership Interests - Texas Oncology
Research Funding - Mary Crowley Research Center, Dallas Texas
 
Ming-Shiang Wu
No Relationships to Disclose
 
Kathleen F. Pirollo
Research Funding - SynerGene Therapeutics
Patents, Royalties, Other Intellectual Property - Georgetown Univ.
 
James F. Strauss
No Relationships to Disclose
 
Wei-Chih Liao
Research Funding - MICROBIO GROUP (Inst)
Patents, Royalties, Other Intellectual Property - NTUH
 
Shih-Hung Yang
Research Funding - ACT Genomics; Ono Pharmaceutical; TTY Biopharm
Travel, Accommodations, Expenses - PharmaEngine
 
Robert Alan Nunan
Employment - Texas Oncology
 
Jana Adams
No Relationships to Disclose
 
Joe B. Harford
Employment - Synergene Therapeutics
Leadership - Synergene Therapeutics
Stock and Other Ownership Interests - Synergene Therapeutics
Consulting or Advisory Role - Synergene Therapeutics (I)
Research Funding - Synergene Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Synergene Therapeutics (I)
Travel, Accommodations, Expenses - Synergene Therapeutics
 
Esther H. Chang
Employment - SynerGene Therapeutics (I)
Leadership - SynerGene Therapeutics (I)
Stock and Other Ownership Interests - SynerGene Therapeutics
Consulting or Advisory Role - SynerGene Therapeutics
Research Funding - SynerGene Therapeutics
Patents, Royalties, Other Intellectual Property - Synergene Therapeutics
Travel, Accommodations, Expenses - SynerGene Therapeutics